Axcella Health ROA Ratio 2011-2026 | AXLA

Annual ROA Ratio Axcella Health

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-428.94	-111.95	-51.58	-62.57	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-51.58	-428.94	-163.76

Quarterly ROA Ratio Axcella Health

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-183.81	-189.67	-128.42	-151.11	-115.85	-92.77	-58.32	-69.67	-58.33	-51.45	-37.72	-56.06	-63.05	-65.68	-45.91	-56.65	-49.04	-45.24	-32.14	-32.14	-21.41	-9.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-9.9	-189.67	-73.38

ROA Ratio of other stocks in the Biotechnology industry

Issuer	ROA Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-20.13	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	-21.14	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	-10.45	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	-11.27	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	-101.11	-	10.36 %	$ 9.8 M	USA
I-Mab IMAB	7.43	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	3.33	-	-	$ 40.3 B	USA
Genfit SA GNFT	23.87	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-89.6	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	-35.36	$ 220.94	2.51 %	$ 5 B	Danmark
Aptinyx APTX	-97.25	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	-42.28	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-53.39	-	-1.52 %	$ 24.7 M	USA
MediWound Ltd. MDWD	-29.6	$ 17.08	2.83 %	$ 465 M	Israel
Amphastar Pharmaceuticals AMPH	6.02	$ 19.7	2.44 %	$ 921 M	USA
Applied Genetic Technologies Corporation AGTC	-27.57	-	-	$ 26.5 M	USA
Mesoblast Limited MESO	-13.8	$ 15.54	8.48 %	$ 10.1 B	Australia
Ayala Pharmaceuticals AYLA	-489.29	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	-123.72	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	-232.99	-	-24.86 %	$ 820 K	USA
Atreca BCEL	-62.67	-	-11.76 %	$ 5.79 M	USA
Acasti Pharma ACST	-13.29	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	3.5	-	0.49 %	$ 251 B	Cayman-islands
Mirum Pharmaceuticals MIRM	-2.77	$ 90.9	3.44 %	$ 4.56 B	USA
bluebird bio BLUE	-34.23	-	-	$ 546 M	USA
Институт стволовых клеток человека ISKJ	4.82	-	-	-	Russia
Cara Therapeutics CARA	-94.17	-	-3.03 %	$ 260 M	USA
Adverum Biotechnologies ADVM	-72.8	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-225.71	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-289.96	-	-9.65 %	$ 45.9 M	USA
MediciNova MNOV	-26.31	$ 1.44	-0.68 %	$ 70.7 M	USA
Avenue Therapeutics ATXI	-437.72	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	-28.19	$ 1.36	3.03 %	$ 347 M	Britain
CytomX Therapeutics CTMX	-11.46	$ 4.41	3.98 %	$ 608 M	USA
Cyclacel Pharmaceuticals CYCC	-273.86	-	-5.98 %	$ 34.1 M	USA
ChemoCentryx CCXI	-30.95	-	-	$ 3.74 B	USA
Merck & Co. MRK	13.34	$ 118.9	2.17 %	$ 297 B	USA
Dynavax Technologies Corporation DVAX	2.77	-	-	$ 2.02 B	USA
BioDelivery Sciences International BDSI	26.14	-	-4.8 %	$ 255 M	USA
Enochian Biosciences ENOB	-2162.69	-	-	$ 40.5 M	USA
Aeglea BioTherapeutics AGLE	-19.95	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-35.55	-	-	$ 867 M	Germany
Bellerophon Therapeutics BLPH	-249.92	-	-74.18 %	$ 955 K	USA
Akero Therapeutics AKRO	-30.52	-	-	$ 3.67 B	USA
Neurocrine Biosciences NBIX	10.33	$ 131.82	3.1 %	$ 13.1 B	USA
Arbutus Biopharma Corporation ABUS	-35.41	$ 4.56	5.68 %	$ 874 M	Canada
Homology Medicines FIXX	48.27	-	0.77 %	$ 53.4 M	USA
Akouos AKUS	-31.09	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	-31.2	-	1.93 %	$ 17.4 M	USA
Allakos ALLK	-76.23	-	-	$ 28.6 M	USA